Stay updated on Proviral Genotype-Guided ART Clinical Trial
Sign up to get notified when there's something new on the Proviral Genotype-Guided ART Clinical Trial page.

Latest updates to the Proviral Genotype-Guided ART Clinical Trial page
- Check3 days agoChange DetectedThe ClinicalTrials.gov footer revision changes from v3.8.0 to v3.8.1.SummaryDifference0.1%

- Check10 days agoChange DetectedThe page now displays the NCT03539224 study record, including its eligibility criteria, treatment plan, locations, and outcome measures, instead of an access-denied error.SummaryDifference41%

- Check17 days agoChange DetectedThe footer’s site revision changed from v3.7.2 to v3.8.0; the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check31 days agoChange DetectedA notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study record still displays a 403 error.SummaryDifference1%

- Check45 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check59 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the detailed study record content with an access-restricted error page. This blocks users from viewing the trial's basic information and related details.SummaryDifference17%

Stay in the know with updates to Proviral Genotype-Guided ART Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Proviral Genotype-Guided ART Clinical Trial page.